Abstract
The authors surveyed 38 psychiatry residents to determine the effect of end-of-residency transfer of care on psychopharmacology patients. Senior residents reported that 19% of patients worsened after notification about the upcoming transfer, 32% required medication changes, and up to 9% became noncompliant. Junior residents reported that, after transfer, 10% of patients worsened, 7% required medication changes, and up to 12% became noncompliant. Approximately 29% of patients considered the change of residents a major treatment disruption. The authors propose a system for minimizing deleterious effects and improving outcome in the transfer of psychopharmacology patients.Preview Only. This article cannot be rented because we do not currently have permission from the publisher.
Preview Only
© 2012 DeepDyve, Inc. All rights reserved.
Terms of Service | Privacy Policy